811 articles published
Research documents a pattern of suppression targeting Arab medical professionals inside Israel since the start of the Gaza conflict.
New research published in Genome Medicine found that variants in an enzyme called PAM cause about 10% of people to show resistance to GLP-1 drugs.
A study of 160,000 UK adults found that every 3.7 additional daily servings raised the risk of hip fractures and reduced bone density at multiple sites.
The World Health Organization confirmed Australia's elimination of trachoma, a bacterial eye infection and leading cause of preventable blindness.
Eli Lilly's newly approved Foundayo pill, priced at $149 per month, is now available through Amazon One Medical kiosks in California with same-day dispensing.
A six-month study found time-restricted eating reduced A1C levels and testosterone in women with polycystic ovary syndrome, without calorie tracking.
Heather Kaiser's tumor, initially dismissed as an ovarian cyst, turned out to be a mass the size of a fist.
Researchers found that personal storytelling makes promotional drug content feel authentic even when it is incomplete or inaccurate.
A Cedars-Sinai study of nearly 670,000 adults found antidepressants used for IBS were tied to a 35% higher risk of death over the long term.
Men taking the diabetes drug showed Lac-Phe levels matching those seen after ultramarathon running, researchers found.
Human trials for the new treatments, which aim to regrow bone and cartilage rather than replace joints, are expected to begin within the next year.
The FDA has six months to complete its own safety review of the drug's prescribing rules under the court's order.
We use cookies to improve your experience and serve relevant ads. See our Privacy Policy for details.
